Fig. 17From: Comprehensive anticancer drug response prediction based on a simple cell line-drug complex network modelBoxplot and ROC curve (the bottom curve indicates drug response) for Irinotecan in CCLE and Dasatinib in GDSC. The left for Irinotecan, p-value by T test is 1.296e-15 and AUC is 0.786. The right for Dasatinib, p-value by T test is 2.470e-11 and AUC is 0.818Back to article page